CR1_Mam
Basic information Differential Expression Stage analysis Survival analysis Correlation analysisThe patients were classified into two groups based on the expression levels of TE families or the identification of TE-initiated transcripts. To assess the statistical difference in survival between the two groups, a log-rank test was performed. The hazard ratio (HR) and p-value were computed using the "survdiff" function from the "survival" package in R.
| Tumor | HR | P_value |
|---|---|---|
| TCGA-LUSC | 0.73 | 0.09 |
| TCGA-TGCT | 0.26 | 0.09 |
| TCGA-LGG | 1.38 | 0.09 |
| TCGA-LAML | 1.43 | 0.10 |
| TCGA-SARC | 0.72 | 0.10 |
| TCGA-CESC | 1.74 | 0.11 |
| TCGA-PRAD | 3.10 | 0.11 |
| TCGA-LUAD | 1.26 | 0.12 |
| TCGA-OV | 0.83 | 0.12 |
| TCGA-BRCA | 1.31 | 0.13 |